544210:BOM
Emcure Pharmaceuticals Ltd
₹1,860.00
arrow_upward
+1.37%(+25.05) 1D
Oct 12, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 544210...
Open
₹1,811.05
High
₹1,897.60
Low
₹1,811.00
Mkt. cap
353.48B
Avg. vol.
30.56K
Volume
6.22K
Dividend
0.19%
Quarterly dividend
₹0.90
Ex-dividend date
Sep 4, 2026
P/E ratio
34.86
52-wk high
₹2,101.00
52-wk low
₹1,307.50
EPS
₹53.35
No. of employees
7K
Open
₹1,811.05
High
₹1,897.60
Low
₹1,811.00
Mkt. cap
353.48B
Avg. vol.
30.56K
Volume
6.22K
Dividend
0.19%
Quarterly dividend
₹0.90
Ex-dividend date
Sep 4, 2026
P/E ratio
34.86
52-wk high
₹2,101.00
52-wk low
₹1,307.50
EPS
₹53.35
No. of employees
7K
News stories
From web sources and news partners
BusinessLine
·
10 hours ago
Emcure Pharmaceuticals approves merger of two wholly-owned subsidiaries
Business Standard
·
14 hours ago
Emcure Pharma up over 3% as board approves merger of two subsidiaries
Profile
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
About Emcure Pharmaceuticals Ltd
CEOSatish Ramanlal Mehta
Employees6.91K
FoundedApr 16, 1981
Headquarters-
SectorPharmaceutical industry
Websiteemcure.com